Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Inulin + guar gum is a combination of two soluble dietary fibers used primarily to support gastrointestinal health and metabolic function. Inulin, a fructan-type polysaccharide, acts as a potent prebiotic, selectively stimulating the growth of beneficial gut bacteria such as Bifidobacteria. Guar gum, a galactomannan derived from the guar bean, provides significant viscosity and bulking properties. Together, these fibers increase stool frequency and consistency, promote satiety, and slow the absorption of dietary carbohydrates and lipids, which can help manage postprandial glucose levels and cholesterol. The combination is widely available as a nutraceutical and has been investigated in clinical trials for its effects on obesity, type 2 diabetes, and irritable bowel syndrome.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on inulin + guar gum.